On July 14, 2022, NACI published guidance on the use of mRNA-1273 in children 6 months to 5 years. This expert brief will review the key recommendations from this guidance and discuss some of the key issues surrounding the discussion of COVID-19 vaccines in young children.
This program has received funding from Moderna.